News briefing: Seer heads to Nasdaq with $150M IPO; IN8bio postpones public debut amid record year on Wall Street
Less than four months after a $55 million raise, Seer is ready to go public.
The company, run by Omid Farokhzad, filed for a $150 million IPO on Thursday as it prepares to jump onto the Nasdaq. Seer’s stock ticker will be fairly simple to remember — $SEER — and the move comes after the company has raised more than $150 million since being founded in 2017.
Thursday’s news also comes less than a month after Seer’s main product, the Proteograph Product Suite, was delivered to one of its first collaborators, per the company’s S-1. Funds from the IPO will go toward further commercializing the product and other R&D-related projects for Proteograph.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
